Federal Court of Appeal rejects ‘novel argument’ for remedy in patent infringement
An argument of remedy for patent infringement brought by Apotex Inc. against Bayer Inc. at the Federal Court of Appeal is being called novel and innovative by patent lawyers, but not...To view the full article, register now.
Already a subscriber? Click here to view full article